Improved FluMist nasal spray approved to return next flu season

The nasal spray has been reformulated and had been off the market for two years because of its poor performance compared to the flu shot

Next Year You'll Be Able to Get Your Flu Shot Without a Needle

Limited quantities of FluMist (which remained licensed but not ACIP-recommended) continue to be available in the USA for the current flu season.

"I have real mixed emotions about this because I think we want to protect as many people as we can, particularly, as a pediatrician, for children", said Dr. Henry Bernstein, a professor of pediatrics at Cohen Children's Medical Center in NY.

Next flu season you'll be able to get your vaccine without a needle.

AstraZeneca says it will supply FluMist to the USA market next season.

Dr. Len Horovitz, a pulmonary specialist from Lenox Hill Hospital in New York City, concurred. For the previous two flu seasons, the CDC has recommended against FluMist use due to efficacy problems, deeply hurting sales for the needle-free flu vaccine option. A review of data from 2013 through 2016 showed that the vaccine offered children nearly no protection against flu; in the 2015-2016 season LAIV protection rate was only 3%.

There is real worry among flu experts that the poor effectiveness of flu vaccines, especially this past season, may make Americans less willing to get it.

De Gea saves Manchester United in Sevilla
Mourinho added: "I'm not relieved because I think we finished the game with more space, with more chances of scoring a goal ". And my answer would be yes, he had a fantastic performance, he looked a senior player".

FluMist will be available in the US for the 2018-2019 influenza season, pending annual strain approval from the FDA.

Even though FluMist has not been recommended for the past two flu seasons, the Food and Drug Administration has still approved it, Nordlund noted.That means immunization providers could still give patients the nasal spray instead of the flu shot if requested although most physicians have not offered it.

In 2016, the CDC committee found that the nasal spray was only 3 percent effective in preventing flu, essentially offering no protection.

The vaccine's maker, AstraZeneca, said a small study shows a new version appears to work better. After the second dose, those results increased to 45% and 12%, respectively. It was licensed in 2003 and was the only non-injection flu vaccine available, the CDC said.

About 84 children in the United States have died from the flu as of February 10, according to the U.S. Centers for Disease Control and Prevention.

Latest News